Association between cystatin C and major adverse cardiac events in patients with ischemic heart disease and type 2 diabetes mellitus after acute coronary syndrome
Purpose. To evaluate the level of cystatin C and its association with the risk of developing repeated major adverse cardiac events (MACE) in patients with ischemic heart disease (IHD) and preserved kidney function in combination with type 2 diabetes mellitus (DM) within 12 months after acute coronar...
Saved in:
| Main Authors: | S. A. Serik, T. H. Ovrakh |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Zaporizhzhia State Medical and Pharmaceutical University
2019-06-01
|
| Series: | Zaporožskij Medicinskij Žurnal |
| Subjects: | |
| Online Access: | http://zmj.zsmu.edu.ua/article/view/168962/169282 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The relationship between indicators of cardiac hemodynamics and types of dyslipidemia in patients with coronary heart disease and type 2 diabetes mellitus
by: A. О. Sypalo, et al.
Published: (2017-06-01) -
Cystatine C role in predicting the in-hospital adverse outcomes of coronary artery bypass graft surgery
by: K. S. Shafranskaya, et al.
Published: (2013-06-01) -
The role of cystatin C in kidney injury in children and adolescents with type 1 diabetes mellitus: a systematic review
by: Nikolaos Gkiourtzis, et al.
Published: (2025-08-01) -
Stratification of patients with type 2 diabetes mellitus for painless ischemic heart disease
by: Natalya Ivanovna Volkova, et al.
Published: (2012-03-01) -
Red blood cell count and cystatin C as the specific biomarkers for diabetic retinopathy from diabetes mellitus: a case–control study
by: Zheng Li, et al.
Published: (2024-11-01)